Collegium Pharmaceutical Inc.

04/07/2026 | Press release | Distributed by Public on 04/07/2026 14:01

Management Change/Compensation (Form 8-K)

Item 5.02 Departure of Directors or Principal Officers; Election of Directors
Director Nominee
On April 6, 2026, the board of directors ("Board") of Collegium Pharmaceutical, Inc. (the "Company") approved the nomination of Michael Donovan to stand for election at the Company's 2026 Annual Meeting of Shareholders (the "Annual Meeting").
Mr. Donovan, 60, has served as an audit Partner at Ernst & Young LLP ("EY") since 2002. He has held several leadership roles at EY including Office Managing Partner of EY's biotechnology office in Kendall Square from 2014 to 2024 and East Region Biotechnology Leader. Mr. Donovan brings to our Board financial expertise obtained from his extensive business, accounting and financial background from over 36 years of experience serving public and private companies in the life sciences industry. During his tenure at EY, he has worked on hundreds of private and public company audits, private and public financings including IPOs, M&A transactions, corporate license and collaboration agreements, spin-outs and product launches. Mr. Donovan received a B.S. in Business Administration from Merrimack College and is a Certified Public Accountant (active).
Director Retirement
On April 2, 2026, John Fallon, M.D., a current member of the Board, advised the Board that he will not stand for re-election at the Annual Meeting and will retire from the Board at that time. Dr. Fallon has served as a director since 2016, and he will continue as a director until the Annual Meeting.
The Company extends its deepest gratitude to Dr. Fallon for his distinguished service to the Board and lasting contributions to the Company.
Dr. Fallon's decision not to stand for re-election is part of the Board's continued focus of board refreshment and board succession planning, and not the result of any disagreement with the Company.
Collegium Pharmaceutical Inc. published this content on April 07, 2026, and is solely responsible for the information contained herein. Distributed via EDGAR on April 07, 2026 at 20:02 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]